Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults
P.J. (Paul) Wichgers Schreur, Wageningen Bioveterinary Research, Netherlands
Time:
US & Europe: 08:00 (PDT) | 11:00 (EDT) | 16:00 (BST) |17:00 (CEST)
South America: 12:00 noon (Argentina) | 10:00 (Mexico)
Africa: 04:00 (West Africa) | 05:00 (South Africa) | 06:00 (East Africa)
Asia: 08:30 (IST) | 11:00 (CST) | 12:00 (KST)
Australia: 23:00 (AWST) | 01:00 (AEST) 1 May | 20:00 1 May (AEDT)
Join the webinar here